Florian Naudet, MD, PhD

Univ Rennes, CHU Rennes, Inserm, Centre d’Investigation Clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France; Corresponding author: Florian Naudet, MD, PhD, Clinical Investigation Center (INSERM 1414), University Hospital, 2 rue Henri Le Guilloux, 35000 Rennes, France ([email protected]).

A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole

Letter to the Editor

A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole

August 3, 2022

This letter comments on methodological aspects of a recent study by Cohen et al.

Florian Naudet, André Gillibert, Barbara Mintzes, et al

Use of Baclofen Harms Alcohol Use Disorder Patients Without Benefit

Letter to the Editor

Use of Baclofen Harms Alcohol Use Disorder Patients Without Benefit

January 12, 2021

In this letter to the editor, the authors comment on a Clinical and Practical Psychopharmacology article recently published in JCP.

Alain Braillon, Florian Naudet